Showing results (201-210 of 385) with videos related to
Sort By:
Pageof 39
Journal of Virus Eradication|February 16, 2022
Bringing social context into global biomedical HIV cure-related research: An urgent call to actionAnnie Miall, Rio McLellan, Krista Dong, et al.Journal of Virus Eradication|July 11, 2022
Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothersWenjun Zhang, Chenyu Xu, Yanjing Rui, et al.Journal of Virus Eradication|September 4, 2023
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centersCaroline Schwarz, Raphael Schubert, Michael Schwarz, et al.Journal of Virus Eradication|September 11, 2023
To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trialsHursch Patel, Karine DubéJournal of Virus Eradication|August 10, 2023
Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]Eunice Akinyi Okumu, Gail E Henderson, Carol Golin, et al.Journal of Virus Eradication|November 9, 2019
Persistence of HIV reservoir following successful haematopoietic stem cell transplant for juvenile myelomonocytic leukaemia in a child with perinatally acquired HIVG Dobson, N Klein, P Veys, et al.Journal of Virus Eradication|November 23, 2019
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-savingStephanie Popping, Brooke Nichols, Bart Rijnders, et al.Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.Journal of Virus Eradication|November 23, 2019
Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in ThailandSivaporn Gatechompol, Kamon Kawkitinarong, Gompol Suwanpimolkul, et al.Journal of Virus Eradication|November 30, 2020
Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count 3 in ThailandWin Min Han, Sasiwimol Ubolyam, Tanakorn Apornpong, et al.Pageof 39